|Date||28 September 2017|
|Fees||*academic: 50 CHF - for-profit: 0 CHF|
|Cancellation deadline||11 Sep 2017|
This course is organised by SIB Swiss Institute of Bioinformatics, in collaboration with the Clinical Pathology Division of the University Hospital of Geneva (HUG).
Cutting-edge technologies, like next-generation-sequencing (NGS) applied to gene panels, combined with the development of targeted therapies are now revolutionising clinical practice in oncology. In this context, clinical bioinformatics plays a pivotal role, ensuring that NGS data are converted into clinically relevant knowledge. While bioinformatics analysis pipelines can be automated to some extent, they still require human expertise to perform robust quality control and annotation/interpretation of somatic variants.
This course therefore aims at deepening the underlying bioinformatics concepts for professionals from clinical labs working on NGS data, to improve their skills for spotting artifacts from NGS data and annotating true somatic variants. This interactive course will consist of lectures alternating with study cases using a bioinformatics pipeline for cancer diagnosis, and group discussions/presentations.
I. NGS BIOINFORMATICS PIPELINE
II: BIOINFORMATICS QUALITY CONTROL
III: ANNOTATION & INTERPRETATION
Priority will be given to members of clinical laboratories in Switzerland with some experience in NGS somatic variant analysis.
Deadline for registration and free-of-charge cancellation is set to 11 September 2017. Cancellation after this date will not be reimbursed. Please note that participation to SIB courses is subject to this and other general conditions, available at http://www.sib.swiss/training/terms-and-conditions.
You will be informed by email of your registration confirmation.
University of Lausanne, exact venue will be communicated to participants in due time.
You are welcome to register to the SIB courses mailing-list to be informed of all future courses and workshops, as well as all important deadlines using the form here.